Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
[Cancer of the pancreas]
Louis Buscail1, Barbara Bournet, Pierre Cordelier
1Gastro-enttrologie et Nutrition, INSERM UMR 1037, Centre de Recherche Contre le Cancer de Toulouse CHU Rangueil-Toulouse. Buscail.L@chu-toulouse.fr
Abstract:
The incidence of pancreatic cancer is increasing but the prognosis remains poor. The lack of clearly identified risk factors hinders screening and early diagnosis (when the disease is still curable). The sole curative treatment is surgical resection, which is feasible in only 15% of patients. Chemotherapy regimens are being developed in an attempt to prolong the survival of patients who do not quality for surgery. Recent advances include better knowledge and treatment of pre-neoplastic pancreatic lesions such as mucinous tumors. Basic and translational researchers are attempting to identify tumoral or circulating antigens that could serve as diagnostic markers and/or therapeutic targets.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Pancreas
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short...
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology

